March 27, 2015 |
Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?
Books espousing behavioural economic theories, such as “Thinking Fast and Slow” authored by Daniel Kahneman, have become essential reading for market researchers looking to improve their understanding of how people think, feel and behave.
This theory can be very useful in consumer research, where we already know the power brands have on influencing purchase decisions. But can behavioural economics theory be applied to the pharmaceutical healthcare industry, where treatment decisions are often made in a highly regulated environment and by educated professionals using sound, rational judgement?
Download and read the complimentary whitepaper at http://bit.ly/1L5YhyM
We are one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges.
This content was provided by Inizio
Latest Content from Inizio
Overview of spondyloarthritis patient profiles and treatment pathways.
How study design which reflects doctors’ real world choices can optimise results.
Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.
Published in eyeforpharma July 29 by Rachel Howard
HCPs predict the future of the biologics market
What do you know about chaos theory?
Published in pharmaphorum July 2015 by Julie Denny
Published in eyeforpharma June 9 by Rachel Howard and Raquel Nunez.
An introduction to the HCV LATAM patient.
Published in eyeforpharma 20 May by Rachel Howard
